Paper28693200
Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells.
Liu T and 6 others. Oncol Lett, 2017. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells. Papers, record 28693200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21289447 | Glycan changes: cancer metastasis and anti-cancer vaccines. | J Biosci | 2010 | https://conductscience.org/library/papers/21289447 | PubMed |
| 2 | 3476546 | Purification and some properties of fucosyltransferase in human parotid saliva. | J Dent Res | 1987 | https://conductscience.org/library/papers/3476546 | PubMed |
| 3 | 15466206 | BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. | Cancer Res | 2004 | https://conductscience.org/library/papers/15466206 | PubMed |
| 4 | 19157620 | Alteration of protein glycosylation in liver diseases. | J Hepatol | 2009 | https://conductscience.org/library/papers/19157620 | PubMed |
| 5 | 10438459 | Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10438459 | PubMed |
| 6 | 24629138 | Comprehensive profiling of accessible surface glycans of mammalian sperm using a lectin microarray. | Clin Proteomics | 2014 | https://conductscience.org/library/papers/24629138 | PubMed |
| 7 | 21921256 | International trends in liver cancer incidence rates. | Cancer Epidemiol Biomarkers Prev | 2011 | https://conductscience.org/library/papers/21921256 | PubMed |
| 8 | 24724545 | Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis. | J Proteome Res | 2014 | https://conductscience.org/library/papers/24724545 | PubMed |
| 9 | 15903293 | Protein glycosylation: new challenges and opportunities. | J Org Chem | 2005 | https://conductscience.org/library/papers/15903293 | PubMed |
| 10 | 17022640 | Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. | J Proteome Res | 2006 | https://conductscience.org/library/papers/17022640 | PubMed |
| 11 | 11819844 | Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. | World J Gastroenterol | 2001 | https://conductscience.org/library/papers/11819844 | PubMed |
| 12 | 23977005 | Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell. | PLoS One | 2013 | https://conductscience.org/library/papers/23977005 | PubMed |
| 13 | 26556863 | Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26556863 | PubMed |
| 14 | 2953071 | Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. | Science | 1987 | https://conductscience.org/library/papers/2953071 | PubMed |
| 15 | 18650514 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18650514 | PubMed |
| 16 | 21538283 | Genetics of hepatobiliary carcinogenesis. | Semin Liver Dis | 2011 | https://conductscience.org/library/papers/21538283 | PubMed |
| 17 | 27203677 | Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27203677 | PubMed |
| 18 | 24255131 | Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma. | Mol Cell Proteomics | 2014 | https://conductscience.org/library/papers/24255131 | PubMed |
| 19 | 25727145 | Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. | Adv Cancer Res | 2015 | https://conductscience.org/library/papers/25727145 | PubMed |
| 20 | 14697136 | [Changes of alkaline phosphatase sugar chains in hepatocellular carcinoma tissue]. | Zhonghua Gan Zang Bing Za Zhi | 2003 | https://conductscience.org/library/papers/14697136 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41961075 | Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/41961075 | PubMed |
| 40368336 | Glycoproteomics of Gastrointestinal Cancers and Its Use in Clinical Diagnostics. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40368336 | PubMed |
| 37920152 | Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/37920152 | PubMed |
| 37609076 | Post-translational modifications and immune responses in liver cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/37609076 | PubMed |
| 37193819 | Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. | Oncogene | 2023 | https://conductscience.org/library/papers/37193819 | PubMed |
| 36072925 | Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36072925 | PubMed |
| 35044085 | Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG). | Cancer Med | 2022 | https://conductscience.org/library/papers/35044085 | PubMed |
| 33728291 | Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models. | Can J Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33728291 | PubMed |
| 33203790 | Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/33203790 | PubMed |
| 31024205 | Hepatocellular Carcinoma: Etiology and Current and Future Drugs. | J Clin Exp Hepatol | 2019 | https://conductscience.org/library/papers/31024205 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28693200
GET https://conductscience.org/api/papers/v1/28693200/references?page=2